Once installed, MASLD and CKD may worsen insulin resistance, dyslipidemia, and hypertension through inflammation, oxidative stress, uremia, metabolic acidosis, sedentarism, and further activation of the renin–angiotensin–aldosterone system [7]. The gene discussed is REN; the disease is metabolic syndrome.